Results 31 to 40 of about 18,796 (241)
A case of dysautonomia after COVID‐19 infection in a patient with poorly controlled type I diabetes
Clinical Case Reports, 2023 COVID‐19 has been linked to dysautonomia in the current literature, as has uncontrolled diabetes. Here, we present a case report of severe dysautonomia following a COVID‐19 infection in a patient with pre‐existing poorly controlled type‐1 diabetes.
Lorry Aitkens, George Downey
doaj +1 more source
Cardiorespiratory dysautonomia in post‐COVID‐19 condition: Manifestations, mechanisms and management
Journal of Internal Medicine, 2023 A significant proportion of COVID‐19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately 1 out of 10 COVID‐19 convalescents reports persistent health issues more than 3 months after
Artur Fedorowski +6 more
semanticscholar +1 more source
BioMed, 2023 Dysautonomia in the post-COVID-19 condition appears to affect a significant number of patients, with reports raising the incidence up to 61%, having an overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
Dimitrios Spaggoulakis +9 more
doaj +1 more source
Veterinary Clinics of North America: Equine Practice, 2018 Equine dysautonomia (ED; also known as equine grass sickness) is a neurological disease of unknown cause, which primarily affects grazing adult horses. The clinical signs reflect degeneration of specific neuronal populations, predominantly within the autonomic and enteric nervous systems, with disease severity and prognosis determined by the extent of ...
McGorum, Bruce C, Pirie, R Scott
openaire +2 more sources
Frontiers in Neurology, 2022 Introduction On March 11, 2020, the World Health Organization sounded the COVID-19 pandemic alarm. While efforts in the first few months focused on reducing the mortality of infected patients, there is increasing data on the effects of long-term ...
Francisco Carmona-Torre +11 more
semanticscholar +1 more source
Dysautonomia in Amyotrophic Lateral Sclerosis
International Journal of Molecular Sciences, 2023 Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, characterized in its typical presentation by a combination of lower and upper motor neuron symptoms, with a progressive course and fatal outcome.
Alexandra L. Oprisan, B. Popescu
semanticscholar +1 more source
The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis
Frontiers in Neurology, 2017 BackgroundMultiple system atrophy (MSA) is a rare, adult-onset, rapidly progressive fatal synucleinopathy that primarily affects oligodendroglial cells in the brain.
Carlos E. Mendoza-Santiesteban +4 more
doaj +1 more source
Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm
ASN Neuro, 2021 Among the plethora of debilitating neurological disorders of COVID-19 syndrome in survivors, the scope of SARS-CoV-2-induced dysautonomia (DNS) is yet to be understood, though the implications are enormous.
H. Al-kuraishy +5 more
semanticscholar +1 more source
A Case of Leporine Dysautonomia from Croatia
Acta Veterinaria, 2022 Leporine dysautonomia (or dysautonomia of hares) is an idiopathic disorder associated with degeneration of neurons of the peripheral nervous system with loss of sympathetic and parasympathetic nerve function.
Huber Doroteja +2 more
doaj +1 more source
Joint Hypermobility Links Neurodivergence to Dysautonomia and Pain
Frontiers in Psychiatry, 2022 Objectives Autism, attention deficit hyperactivity disorder (ADHD), and tic disorder (Tourette syndrome; TS) are neurodevelopmental conditions that frequently co-occur and impact psychological, social, and emotional processes.
Jenny L. L. Csecs +12 more
semanticscholar +1 more source